| |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AB Establishment Expenses | 1 463.00 | 1 463.00 | | 1 463.00 |
BJ TOTAL (I) | 4 632 586.00 | 1 463.00 | 4 631 122.00 | 4 632 586.00 |
BZ Other receivables | 956.00 | | 956.00 | 956.00 |
CF Cash and cash equivalents | 5.00 | | 5.00 | 5.00 |
CJ TOTAL (II) | 962.00 | | 962.00 | 962.00 |
CO Grand total (0 to V) | 4 633 548.00 | 1 463.00 | 4 632 084.00 | 4 633 548.00 |
CU Other investments | 4 631 122.00 | | 4 631 122.00 | 4 631 122.00 |
| |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | | |
DA Share or individual capital | 4 199 280.00 | | | 4 199 280.00 |
DH Retained earnings | -27 527.00 | | | -27 527.00 |
DI RESULTS FOR THE YEAR (Profit or Loss) | -2 320.00 | | | -2 320.00 |
DK Regulated provisions | 13 042.00 | | | 13 042.00 |
DL TOTAL (I) | 4 182 474.00 | | | 4 182 474.00 |
DV Miscellaneous Loans and Financial Debts (4) | 445 161.00 | | | 445 161.00 |
DX Trade payables and related accounts | 4 387.00 | | | 4 387.00 |
EA Other liabilities | 62.00 | | | 62.00 |
EC TOTAL (IV) | 449 610.00 | | | 449 610.00 |
EE Grand total (I to V) | 4 632 084.00 | | | 4 632 084.00 |
EG Accrued income and payables due within one year | 449 610.00 | | | 449 610.00 |
| |
| 5 - Fixed assets increase - decrease | Gross value at beginning of year - Item by item | Revaluation - Disposals | Acquisition - Gross value at year-end | |
0G ACQUISITIONS Total General Total | 4 632 586.00 | | | 4 632 586.00 |
CZ ACQUISITIONS: Establishment, Development, or Research Expenses | 1 463.00 | | | 1 463.00 |
I3 DECREASES Total Financial Fixed Assets | | | 4 631 122.00 | |
I4 DECREASES Grand Total | | | 4 632 586.00 | |
IN DECREASES Start-up, development, or research expenses | | | 1 463.00 | |
LQ ACQUISITIONS Total Financial Fixed Assets | 4 631 122.00 | | | 4 631 122.00 |
| |
| 6 - Depreciation | Amount at beginning of year | Increase: allocation for the year | Diminution reprise | Year-end amount |
0N DEPRECIATION Grand Total | 1 463.00 | | | 1 463.00 |
CY DEPRECIATION Start-up, development, or research expenses | 1 463.00 | | | 1 463.00 |
| |
| 7 - Provisions | Amount at beginning of year | Increase: allocation for the year | Diminution reprise | Year-end amount |
3X Extraordinary depreciation | | | | |
3Z Total regulated provisions | 13 042.00 | | | 13 042.00 |
7C Grand total | 13 042.00 | | | 13 042.00 |
| |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 4 387.00 | 4 387.00 | | 4 387.00 |
8K Other liabilities (including liabilities related to repo transactions) | 62.00 | 62.00 | | 62.00 |
VB VAT | 956.00 | | | 956.00 |
VI Group and Associates | 445 161.00 | 445 161.00 | | 445 161.00 |
VT TOTAL – STATEMENT OF RECEIVABLES | 956.00 | 956.00 | | 956.00 |
VY TOTAL – STATEMENT OF LIABILITIES | 449 610.00 | 449 610.00 | | 449 610.00 |
